Dolby Laboratories, Inc. (DLB)
Dolby Laboratories, Inc. (DLB)
| Cash Flow | 2026-03-27 | 2025-12-26 | 2025-09-26 | 2025-06-27 |
|---|---|---|---|---|
| Revenue from contract with customer | NaN | NaN | 1,349,130 | NaN |
| Cost of revenue-Total Licensing Revenue | NaN | NaN | 83,619 | NaN |
| Cost of revenue-Products And Services | NaN | NaN | 76,513 | NaN |
| Research and development | NaN | NaN | 261,792 | NaN |
| Sales and marketing | NaN | NaN | 360,711 | NaN |
| General and administrative | NaN | NaN | 286,529 | NaN |
| Restructuring charges | NaN | NaN | 15,007 | NaN |
| Interest income/(expense), net | NaN | NaN | 15,376 | NaN |
| Other income, net | NaN | NaN | 23,150 | NaN |
| Provision for income taxes | NaN | NaN | 46,993 | NaN |
| Net income including noncontrolling interest | 95,454 | 53,681 | 49,654 | 206,838 |
| Depreciation and amortization | 24,097 | 24,145 | 21,998 | 65,829 |
| Stock-based compensation | 30,708 | 37,211 | 31,052 | 97,462 |
| Amortization of operating lease right-of-use assets | 2,749 | 2,668 | 2,577 | 8,193 |
| Amortization of premium on investments | NaN | NaN | 0 | 0 |
| Provision for credit losses | 2,899 | 792 | -148 | 2,582 |
| Deferred income taxes | 5,196 | 16 | 14,134 | -9,146 |
| Impairment loss on internally developed software | NaN | NaN | 0 | NaN |
| Share of net income of equity method investees, net of cash distributions | -3,343 | 5,276 | 707 | NaN |
| Other non-cash items affecting net income | -149 | 1,890 | -16,445 | 17,553 |
| Accounts receivable, net | 21,127 | 82,956 | 33,697 | -15,234 |
| Contract assets, net | 40,650 | 19,824 | -23,582 | 6,902 |
| Inventories | -2,974 | -879 | -3,999 | -4,020 |
| Operating lease right-of-use assets | 12,367 | 4,810 | 2,788 | 1,717 |
| Prepaid expenses and other assets | 30,690 | 3,152 | 31,749 | -46,972 |
| Accounts payable and accrued liabilities | 39,298 | 43,575 | 71,830 | -48,979 |
| Income taxes, net | -10,461 | 4,394 | -44,724 | 1,895 |
| Contract liabilities | 650 | 6,828 | -4,018 | -1,061 |
| Operating lease liabilities | 9,477 | 1,552 | -266 | -8,237 |
| Other non-current liabilities | -9,193 | -3,034 | 5,657 | -6,063 |
| Net cash provided by operating activities | 92,506 | 54,799 | 122,831 | 349,367 |
| Proceeds from maturities of available-for-sale securities | NaN | NaN | 0 | 0 |
| Proceeds from sale of assets | NaN | NaN | 0 | 16,881 |
| Purchases of marketable securities | NaN | NaN | 0 | 0 |
| Proceeds from sales of marketable securities | 0 | NaN | 0 | 15,911 |
| Proceeds from sale of assets held for sale | 0 | NaN | NaN | NaN |
| Proceeds from sale of intangible assets | 0 | 6,623 | NaN | NaN |
| Purchases of property, plant, and equipment | 9,062 | 4,628 | 16,244 | 20,104 |
| Business combinations, net of cash and restricted cash acquired, and other related payments | 0 | 0 | 0 | 1,362 |
| Purchases of intangible assets | 37,025 | 750 | 5,593 | NaN |
| Purchases of other investments | NaN | NaN | 75 | NaN |
| Net cash provided by/(used in) investing activities | -46,087 | 1,245 | -21,912 | 11,326 |
| Proceeds from issuance of common stock | 1,040 | 14,253 | 5,016 | 38,681 |
| Repurchase of common stock | 64,999 | 70,005 | 35,002 | 89,990 |
| Payment of excise tax on repurchase of common stock | -261 | NaN | NaN | 261 |
| Payment of cash dividend | 34,335 | 34,339 | 31,589 | 95,010 |
| Distributions to noncontrolling interest | 559 | 547 | 398 | 1,449 |
| Payment of excise tax on repurchase of common stock | NaN | NaN | 261 | NaN |
| Purchase of noncontrolling interest in business combinations | NaN | NaN | 0 | NaN |
| Equity issued in connection with business combination | NaN | NaN | 0 | NaN |
| Shares repurchased for tax withholdings on vesting of restricted stock | 1,026 | 31,196 | 2,082 | 35,154 |
| Equity issued in connection with business combination | NaN | NaN | NaN | 0 |
| Payments for deferred consideration | NaN | NaN | 0 | NaN |
| Net cash used in financing activities | -99,879 | -121,834 | -64,055 | -183,183 |
| Effect of foreign exchange rate changes on cash and cash equivalents | NaN | NaN | 1,235 | NaN |
| Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | -301 | -1,307 | NaN | 1,302 |
| Net increase/(decrease) in cash, cash equivalents, and restricted cash | -53,761 | -65,795 | 36,797 | 178,812 |
| Cash, cash equivalents, and restricted cash at beginning of period | 727,566 | 793,361 | 577,752 | NaN |
| Cash, cash equivalents, and restricted cash at end of period | 673,805 | 727,566 | 793,361 | NaN |